We are thrilled that all seven #NuCapCure partner institutions came together at the invitation of our project coordinator 𝗧𝗵𝗲𝗼𝗱𝗼𝘀𝘀𝗶𝘀 𝗧𝗵𝗲𝗼𝗱𝗼𝘀𝘀𝗶𝗼𝘂 at the @UniOslo 🇳🇴 for the kick-off meeting since Wednesday❗
Yet another round of #FRINGE experiments at Rez with the hottest temperature in Czech Republic. We are optimizing the cell experiments and preparing the ground for animal experiments in the fall/winter of 2023. @EU_H2020 @fet_eu @FETFX_EU
https://t.co/LB6su88rzI
Yet another visit to the reactor at Centrum výzkumu Řež for #FRINGE cell experiments (19-May - 09 June). In this visit we also started paving the way for animal experiments, hopefully to start in Late autumn 2023.
#glioblastoma#neutroncancertherapies@EU_H2020 @fet_eu @FETFX_EU
The infrastructure for proton therapy of ocular cancer at the Paul Scherrer Institute proton centre gives an outstanding cure ratio. Great hospitality and a wonderful tour of the facilities!
Today we'll play with porphyrins at the UdG Researcher's Nit to show how these donut-shaped, aromatic molecules can transport metals and be used to fight against cancer (and promote our @FRINGE_FETOpen and Beatriu de Pinós)
Thank you @TatianaKerentseva for giving valuable publicity to our recent work. -Potentially valuable repurposing of an already approved drug-@medacPharmaUK@PhotocureASA@Cancers_MDPI@SunPharma_US https://t.co/DI9vOZmarg
5 ALA Is a Potent Lactate Dehydrogenase Inhibitor But Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5 ALA-Mediated Anticancer Action https://t.co/bjIY4mkjfF #mdpicancers via @Cancers_MDPI
Happy to share our new article, on a neglected property of 5-ALA!